Feb 13
|
SpringWorks Therapeutics (SWTX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
|
Feb 13
|
Unveiling BioMarin (BMRN) Q4 Outlook: Wall Street Estimates for Key Metrics
|
Feb 12
|
BMRN vs. CSLLY: Which Stock Is the Better Value Option?
|
Feb 12
|
BioMarin Pharmaceutical (BMRN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
|
Feb 12
|
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
|
Feb 8
|
Why BioMarin Pharmaceutical Inc. (BMRN) Is Among the Best Healthcare Stocks To Buy According to Analysts
|
Feb 5
|
3 Reasons Growth Investors Will Love BioMarin (BMRN)
|
Feb 5
|
BioMarin to Host Fourth Quarter and Full-Year 2024 Financial Results Conference Call and Webcast on Wednesday, February 19, 2025, at 4:30pm ET
|
Feb 5
|
Zacks.com featured highlights BioMarin, Cheesecake Factory, Leidos and The Ensign
|
Feb 4
|
Tasso and Arup to develop blood testing services for clinical research
|
Feb 4
|
4 Stocks That Sport Impressive Interest Coverage Ratio
|
Feb 3
|
Will Non-COVID Drugs Drive PFE's Top Line in Q4 Earnings?
|
Jan 28
|
FDA Expands Label of AZN's Enhertu for New Breast Cancer Indication
|
Jan 27
|
Is BioMarin Pharmaceutical (BMRN) the Best Depressed Stock to Invest in Now?
|
Jan 27
|
BMRN vs. CSLLY: Which Stock Should Value Investors Buy Now?
|
Jan 27
|
NVO Stock Rises as New Obesity Drug Shows Superior Weight Loss
|
Jan 27
|
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock
|
Jan 23
|
Why Is Andreas Halvorsen Bullish On BioMarin Pharmaceutical Inc. (BMRN) Now?
|
Jan 23
|
Zacks.com featured highlights include BioMarin, Amazon.com, Leidos and The Ensign
|
Jan 3
|
10 Magnificent Stocks That Can Make You Richer in 2025
|